×

Immunomodulation using placental stem cells

  • US 8,895,256 B2
  • Filed: 05/17/2012
  • Issued: 11/25/2014
  • Est. Priority Date: 10/13/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of suppressing or reducing a disease-associated immune response in a subject comprising administering a therapeutically effective amount of placental stem cells to the subject, wherein said placental stem cells suppress T cell proliferation stimulated by Epstein-Barr virus antigen-presenting B cells;

  • andwherein at least 80% of said placental stem cells express CD200.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×